Guyatt G, Rennie D, Meade MO & Cook DJ. Users¡¯ Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 3rd ed., New York, USA: McGraw Hill Education & The JAMA Network. 2015.
DiCenzo R, ed. Clinical Pharmacist's Guide to Biostatistics and Literature Evaluation. 2nd ed., Lenexa, KS, USA: American College of Clinical Pharmacy. 2015.
Browner WS, Thomas B Newman TB, Cummings SR. Designing Clinical Research. 5th ed. Wolters Kluwer. 2022.
Malone PM, Witt BA, Malone MJ, Peterson DM. Drug Information: A Guide for Pharmacists, 7th ed. McGraw Hill. 2022.
Canadian Medical Association Journal (CMAJ) evidence based medicine (EBM) series
Wyer PC, et al. Tips for learning and teaching evidence-based medicine: Introduction to the series. CMAJ 2004;171:347-8.
Barratt A, et al. Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat. CMAJ 2004;171:353-8.
Montoria VM, et al. Tips for learners of evidence-based medicine: 2. Measures of precision (confidence intervals). CMAJ 2005;171:611-5.
IDSA 2024 guidance on the treatment of antimicrobial resistant Gram-negative infections :
https://www.idsociety.org/practice-guideline/amr-guidance/
[°¨¿°Áúȯ]
¿¹¹æÁ¢Á¾
A. ¼ºÀÎ ¿¹¹æÁ¢Á¾ ÀÏÁ¤Ç¥:
https://nip.kdca.go.kr/irhp/infm/goVcntInfo.do?menuLv=1&menuCd=115
B. 2025³â ¼ºÀο¹¹æÁ¢Á¾ °³Á¤¾È(Æó·Å):
https://www.ksid.or.kr/introduce/file/vaccine_rule_2025_02(%EC%88%98%EC%A0%95).pdf
C. ¡®24~¡¯25Àý±â Äڷγª19 Àӽÿ¹¹æÁ¢Á¾ Áö¿ø»ç¾÷ Áöħ:
https://www.kdca.go.kr/board/board.es?mid=a20507020000&bid=0019&list_no=726127&act=view
ÁßÃ߽Űæ°è°¨¿°
A. (±¹³») ¼ºÀÎ ¼¼±Õ¼º ¼ö¸·¿°ÀÇ ÀÓ»óÁø·áÁöħ ±Ç°í¾È:
http://dx.doi.org/10.3947/ic.2012.44.3.140
B. (¹Ì±¹) Practice guidelines for the management of bacterial meningitis:
https://www.idsociety.org/practice-guideline/bacterial-meningitis/
Æó·Å
A. (±¹³») ¼ºÀÎ Áö¿ª»çȸȹµæ Æó·Å Ç×»ýÁ¦ »ç¿ëÁöħ:
https://www.kdca.go.kr/board/board.es?mid=a20310030000&bid=0132&tag=&act=view&list_no=726461
B. (±¹³») ¼ºÀκ´¿øÈ¹µæÆó·Å Áø·á ¹× Ç×»ýÁ¦ »ç¿ëÁöħ:
https://www.kdca.go.kr/board/board.es?mid=a20310030000&bid=0132&tag=&act=view&list_no=726465
C. (¹Ì±¹) ATS/IDSA guidelines for diagnosis and treatment of adults with community-acquired pneumonia:
https://www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults/
D. (¹Ì±¹) ATS/IDSA 2016 clinical practice guidelines for the management of adults with hospital-acquired and ventilator-associated pneumonia:
https://www.idsociety.org/practice-guideline/hap_vap/
»ó±âµµ°¨¿°
A. (±¹³») ¼ºÀÎ ±Þ¼º »ó±âµµ °¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ:
https://www.kdca.go.kr/board/board.es?mid=a20310030000&bid=0132&tag=&act=view&list_no=726460
B. (±¹³») ¼Ò¾Æ ±Þ¼º »ó±âµµ °¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ:
https://www.kdca.go.kr/board/board.es?mid=a20310030000&bid=0132&tag=&act=view&list_no=726458
C. (±¹³») 2014³â °³Á¤ÆÇ À¯¼Ò¾Æ ÁßÀÌ¿° Áø·áÁöħ:
https://www.otologicalsociety.or.kr/member/file/2014_01.pdf
ÀÎÇ÷翣ÀÚ
A. (±¹³») 2025-2026Àý±â ÀÎÇ÷翣ÀÚ °ü¸® Áöħ(PART II. °¢·Ð):
https://www.kdca.go.kr/board/board.es?mid=a20604000000&bid=0019&tag=&act=view&list_no=728747
B. (¹Ì±¹) Clinical practice guidelines for the diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza: 2018 update by IDSA:
https://www.idsociety.org/practice-guideline/influenza/
Äڷγª19 °¨¿°
A. (±¹³») Äڷγª19 Ä¡·áÁ¦ »ç¿ë ¾È³»¼(13-2ÆÇ) °³Á¤:
https://www.kdca.go.kr/board/boardApi.es?mid=a20507050000&bid=0080&api_code=20220214
B. (¹Ì±¹) IDSA guidelines on the treatment and management of patients with COVID-19:
https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/
ÇÇºÎ¿Í ¿¬Á¶Á÷ °¨¿°
A. (±¹³») ÇǺΠ¿¬Á¶Á÷ °¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ:
https://www.kdca.go.kr/board/board.es?mid=a20310030000&bid=0132&tag=&act=view&list_no=726462
B. (¹Ì±¹) IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections:
https://www.idsociety.org/practice-guideline/diabetic-foot-infections/
°¨¿°½É³»¸·¿°
A. (±¹³») ½ÉÇ÷°ü°è °¨¿° Áø·áÁöħ ±Ç°í¾È:
https://doi.org/10.3947/ic.2011.43.2.129
B. (¹Ì±¹) Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications:
https://www.idsociety.org/practice-guideline/endocarditis-management/
°áÇÙ
A. °áÇÙ Áø·áÁöħ(5ÆÇ) (2024):
https://www.kdca.go.kr/board/board.es?mid=a20507020000&bid=0019&tag=&act=view&list_no=724490
À§Àå°ü°¨¿°°ú º¹°³»°¨¿°
A. (±¹³») ¼Òȱâ°è °¨¿° Áø·áÁöħ ±Ç°í¾È:
https://doi.org/10.3947/ic.2010.42.6.323
B. (±¹³») ¼ºÀÎ º¹° ³» °¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ:
https://doi.org/10.3947/ic.2022.0156
C. (±¹³») ±Þ¼ºÀ§Àå°ü°è °¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ:
https://www.kdca.go.kr/board/board.es?mid=a20310030000&bid=0132&tag=&act=view&list_no=726464
D. (±¹³») 2022 ´ëÇѰ£ÇÐȸ ¸¸¼ºBÇü°£¿° Áø·á °¡À̵å¶óÀÎ:
https://www.kasl.org/bbs/?number=5349&mode=view&code=guide&keyfield=&keyword=&category=A&gubun=&orderfield=
E. (±¹³») 2025 ´ëÇѰ£ÇÐȸ CÇü°£¿° Áø·á °¡À̵å¶óÀÎ:
https://www.kasl.org/bbs/?number=6192&mode=view&code=guide&keyfield=&keyword=&category=B&gubun=&orderfield=
F. (¹Ì±¹) Clinical practice guidelines for the management of Clostridioides difficile infection in adults: 2021 update by SHEA/IDSA:
https://www.idsociety.org/practice-guideline/clostridioides-difficile-2021-focused-update/
G. (¹Ì±¹) Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by SHEA/IDSA:
https://www.idsociety.org/practice-guideline/clostridium-difficile/
H. (¹Ì±¹) IDSA 2017 clinical practice guidelines for the diagnosis and management of infectious diarrhea:
https://www.idsociety.org/practice-guideline/infectious-diarrhea/
°ñ°üÀý°¨¿°
A. (±¹³») ±¹³» °ñ°üÀý°¨¿° Ç×±Õ¿ä¹ý ±Ç°í¾È:
https://doi.org/10.3947/ic.2014.46.2.125
B. (¹Ì±¹) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America:
https://academic.oup.com/cid/article/56/1/e1/415705?login=false
C. (¹Ì±¹) IDSA 2015 clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults:
https://www.idsociety.org/practice-guideline/vertebral-osteomyelitis/
¿ä·Î°¨¿°
A. (±¹³») ¿ä·Î°¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ:
https://www.kdca.go.kr/board/board.es?mid=a20310030000&bid=0132&tag=&act=view&list_no=726463
¼º¸Å°³°¨¿°
A. (±¹³») ¼º¸Å°³°¨¿° Áø·áÁöħ(2023):
https://www.uti.or.kr/include/pdf/KOREAN_STI_GUIDELINES_2023.pdf
Áø±Õ°¨¿°
A. (¹Ì±¹) Clinical practice guideline for the management of candidiasis: 2016 update by IDSA:
https://www.idsociety.org/practice-guideline/candidiasis/
B. (¹Ì±¹) Clinical practice guideline for the diagnosis and management of aspergillosis: 2016 update by IDSA:
https://www.idsociety.org/practice-guideline/aspergillosis/
B. (¹Ì±¹) Clinical practice guidelines for antimicrobial prophylaxis in surgery:
https://www.ashp.org/surgical-guidelines
»ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º°¨¿° ¹× ±âȸ°¨¿°
A. (±¹³») HIV °¨¿°ÀÇ Áø´Ü°ú Ä¡·á:
https://doi.org/10.3947/ic.2021.0305
B. (±¹³») HIV °¨¿°ÀÎÀÇ ±âȸ°¨¿°Áõ Ä¡·á¿Í ¿¹¹æ:
https://doi.org/10.3947/ic.2016.48.1.54
C. (±¹³») ±¹³» HIV ³ëÃâ Àü ¿¹¹æ¿ä¹ý ±Ç°í¾È:
https://www.icjournal.org/src/sm/ic-49-243-s001.pdf
D. (±¹³») HIV °¨¿°ÀÎ Áø·á¸¦ À§ÇÑ ÀÇ·á±â°ü ±æ¶óÀâÀÌ:
https://www.kdca.go.kr/board/board.es?mid=a20507020000&bid=0019&list_no=726253&act=view
E. (¹Ì±¹) Guidelines for the use of antiretroviral agents in adults and adolescents with HIV:
https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/whats-new
F. (¹Ì±¹) Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/whats-new